Sanofi (SNYNF) Interest Coverage Ratio (2009 - 2026)
Sanofi (SNYNF) posted Interest Coverage Ratio of 69.1 for Q1 2026, down 237.91% sequentially from 20.45 in Q4 2025, and down 24.18% YoY from 91.13 in Q1 2025.
Sanofi (SNYNF) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Sanofi (SNYNF) has 18 years of Interest Coverage Ratio data on file, last reported at 69.1 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 24.18% year-over-year to 69.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 50.21 (down 56.51% YoY) and the FY2025 annual result came in at 11.27, up 66.72% from the prior year.
- Interest Coverage Ratio fell to 69.1 in Q1 2026 per SNYNF's latest filing, from 20.45 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 20.45 in Q4 2025, with the low at 136.51 in Q3 2022.
- Average Interest Coverage Ratio over 5 years is 68.38, with a median of 59.04 recorded in 2023.
- Year-over-year, Interest Coverage Ratio jumped 69.23% in 2023 and tumbled 142.7% in 2025.
- Sanofi's Interest Coverage Ratio stood at 118.2 in 2022, then soared by 68.15% to 37.65 in 2023, then soared by 42.24% to 21.75 in 2024, then climbed by 5.97% to 20.45 in 2025, then slumped by 237.91% to 69.1 in 2026.
- Business Quant data shows SNYNF's Interest Coverage Ratio at 69.1 in Q1 2026, 20.45 in Q4 2025, and 64.91 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 23.39 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -10.80 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | -69.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.10 |
| Dec 31, 2025 | -20.45 |
| Sep 30, 2025 | -64.91 |
| Jun 30, 2025 | -82.84 |
| Mar 31, 2025 | -55.64 |
| Dec 31, 2024 | -21.75 |
| Sep 30, 2024 | -52.91 |
| Jun 30, 2024 | -34.13 |
| Mar 31, 2024 | -45.15 |
| Dec 31, 2023 | -37.65 |
| Sep 30, 2023 | -42.01 |
| Jun 30, 2023 | -59.04 |
| Mar 31, 2023 | -72.58 |
| Dec 31, 2022 | -45.93 |
| Sep 30, 2022 | -136.51 |
| Jun 30, 2022 | -122.19 |
| Mar 31, 2022 | -127.45 |
| Dec 31, 2021 | -242.08 |
| Sep 30, 2021 | -131.90 |
| Jun 30, 2021 | -112.30 |